Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond - Test2 - elhamkhani - TriplyDB

Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond

Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond

http://www.wikidata.org/entity/Q27027039

about

Pre-eclampsia: its pathogenesis and pathophysiolgy Angiotensin Receptors: Structure, Function, Signaling and Clinical Applications Preeclampsia: long-term consequences for vascular health Antibodies in the pathogenesis of hypertension The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?Pre-eclampsia part 1: current understanding of its pathophysiology.Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II-Induced Renal Vascular Sensitivity and Reduce Renal Function During Pregnancy.The immunological basis of hypertension Autoimmunity: an underlying factor in the pathogenesis of hypertension.Novel retro-inverso peptide inhibitor reverses angiotensin receptor autoantibody-induced hypertension in the rabbit Structure of the Angiotensin receptor revealed by serial femtosecond crystallography.Hypertension and immunity: mechanisms of T cell activation and pathways of hypertension.AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Role of immune cells in salt-sensitive hypertension and renal injury.Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor.Elevated placental adenosine signaling contributes to the pathogenesis of preeclampsia.Hypoxia-independent upregulation of placental hypoxia inducible factor-1α gene expression contributes to the pathogenesis of preeclampsia.Apoptotic and stress signaling markers are augmented in preeclamptic placenta and umbilical cord Role of agonistic autoantibodies against type-1 angiotensin II receptor in the pathogenesis of retinopathy in preeclampsia.Identifying immune mechanisms mediating the hypertension during preeclampsia Transglutaminase is a Critical Link Between Inflammation and Hypertension.Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia.Increased risk of systemic lupus erythematosus in pregnancy-induced hypertension: A nationwide population-based retrospective cohort study.Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications.Consensus strategy in genes prioritization and combined bioinformatics analysis for preeclampsia pathogenesis Impact of Immune Deficiency on Remodeling of Maternal Resistance Vasculature 4 Weeks Postpartum in Mice.The importance of non-HLA antibodies in transplantation.Preeclampsia and the brain: neural control of cardiovascular changes during pregnancy and neurological outcomes of preeclampsia.Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase.Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives.Pathogenesis of systemic sclerosis-current concept and emerging treatments.Role of the Immune System in Hypertension.Autoantibody profiling on a plasmonic nano-gold chip for the early detection of hypertensive heart disease.Autoantibodies Toward the Angiotensin 2 Type 1 Receptor: A Novel Autoantibody in Alzheimer's Disease.Ferulic acid alleviates symptoms of preeclampsia in rats by upregulating vascular endothelial growth factor.Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal.Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study.Complement activation, a threat to pregnancy.Autoantibodies against angiotensin and adrenergic receptors: more than a biomarker?

P2860

Q26746841-8B4B279D-4768-47E0-81C9-B43DE496E5F8 Q26779600-5A4B2430-5428-4F00-94CC-6E8D4AB20AD5 Q26800272-43AB8D6E-A979-40C4-9ECE-BEE6521ABAEA Q26828588-0E882153-55F8-456D-9344-8F70C3EEDB16 Q27003301-AE8565ED-B362-44EA-9329-F1BBB947833D Q33416340-9F241ABA-96DE-4716-B85A-6BB9AA5EB692 Q34541831-9DE4C306-1FC2-4796-AA30-1C5D62D663BC Q34683745-BAF73AE8-58ED-4C5B-BC37-DC4EC6718184 Q35116086-7EB5C223-F6C3-44D9-88DD-D268E7C951E2 Q35175458-B585C46E-5443-44AD-B73A-458FCE1EB095 Q35592165-22D7918C-A9F2-41AC-A74D-1BC1351F1C92 Q35983558-91F72985-21FA-4BC2-9523-4C7169913907 Q36052778-0AAB5253-8F0F-4E79-BFE0-7CAC5FD80817 Q36241932-5775257A-85DF-4EB5-B7E5-0E0456F13079 Q36496133-ABFDF12C-14CE-4248-BC53-5B0790E847F9 Q36556973-BE4D4D41-F978-4126-A5CA-B94864C6FFD6 Q36575544-A0A0470E-08FB-4004-AE38-489EEF490B46 Q36879266-523E3DF5-D7B9-48CB-8474-20322E2E1EF9 Q37000033-3D9AA883-4A2B-45AA-BF74-0A81512FED6A Q37067705-55122212-8F70-4324-A509-72E3C9AFCA19 Q37139722-D38E48DE-2A2E-474F-9BE2-39EC5B67C211 Q37240779-B1AF2E36-43B9-4802-AF9A-C2096A34FA5D Q37451544-FCE2BCF6-BAC9-4429-A653-0E4379C60159 Q37605722-5A160E35-813F-4E08-92AC-FDF1DEBCC469 Q37642331-18B9A071-5F91-4601-98F5-AF363337FC10 Q38430192-03719DD6-D610-41FF-B926-BAD28F8B827F Q38789230-3319365B-2E6C-492F-A389-AD511E6EC7FB Q38877375-F3329BEA-AF93-452E-9FA5-D2401A932D01 Q38889590-A7ED19C1-3E67-425F-9BBF-48A71994DF65 Q39198610-CD096506-CA83-423B-81A5-E136F990B69E Q39208841-B0EB7913-8F2E-446F-8A8B-FFA32A50A1FD Q39294794-170CD64A-77E3-4878-86AB-834240C5348A Q39342382-3737CFD1-8BC2-4ACA-AA7D-9F05E22FCE09 Q40153619-9A65214C-B372-4B3C-B74D-D89739B6FAD4 Q41325907-9A370D01-76E3-4F80-B3F8-3B8FD42ACA79 Q46303776-506499BD-E49A-45DE-9237-DAB2D4D87E85 Q47841212-58AFA73C-21C7-48C8-B439-1BBE771CD405 Q48160896-5CD4163E-9BF4-4D9B-8906-E343314A837D Q48662976-DC1869C6-E08F-45B6-8944-AFA367648ED1 Q50077615-E3C05C5C-8633-424E-99D7-2FD3EB48A1D5

P2860

Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond

http://www.wikidata.org/entity/Q27027039

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond

@ast

Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond

@en

Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond

@nl

type

label

Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond

@ast

Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond

@en

Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond

@nl

prefLabel

Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond

@ast

Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond

@en

Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond

@nl

P1433

Q27027039-D0F00FD7-226B-48FD-BE89-330837A19D36

P1476

Q27027039-3FC881F9-5B14-44DB-A3FC-1576617CEE79

P2093

Q27027039-A5132150-BD8E-4245-BA7A-DE0A4CED59E5

Q27027039-E7327B80-3AD1-42E2-98FE-F2BC0CC62C97

P2860

Q27027039-02BE8663-386F-41EF-9C75-DF99AD575586

Q27027039-04C8C7C9-6807-4999-BAEE-F272C174241E

Q27027039-13B577CF-0EA7-41F9-96F4-CF8F56C3632B

Q27027039-13B5A354-B09B-4B6A-A897-A52C17063E66

Q27027039-1BA13694-8483-4684-A545-59E206D13CAB

Q27027039-22CF9A52-625F-490D-9A8B-05988D8710E3

Q27027039-26B3D32B-88CB-49B0-88BB-3DCC0731C50D

Q27027039-2C2511FC-2E35-4987-8C3D-C69D6BD4D654

Q27027039-3405721E-273A-40DC-99DA-EDB810317569

Q27027039-374229B7-B96D-4103-9A8C-6A7202F25734

P304

Q27027039-31D126F0-1A3C-42C7-9957-194755C5EAA9

P31

Q27027039-7895AB72-FD0C-4867-A8E7-F04E42E16AF7

P3181

Q27027039-DCB400C3-7184-4FD7-9F19-52994D05023D

P356

Q27027039-2A602DF5-FE69-4658-99EB-4ADE7A0506C3

P407

Q27027039-A5F0A70A-16B3-4A22-A5B1-DE9B12475608

P433

Q27027039-34318B12-4583-437F-B278-66A60B2A852B

P478

Q27027039-6B736319-86DE-4A62-9A44-F1CF91D365AF

P577

Q27027039-112C45B6-A50B-449A-8479-91C8122DD3AD

P698

Q27027039-65F2BCA6-F577-41AD-91F9-83F2A54B77E2

P921

Q27027039-8FAA0F71-F0D4-45AF-AFA2-2AD3D6135BE6

Q27027039-DC175756-60D1-4ED7-B9FB-9A28BA1AD5FE

Q27027039-E180319F-2A98-4A0C-A74C-5E49D8F9EADC

P932

Q27027039-06298A27-FAFA-40C7-B3B4-16BEDAC7F657

P3181

P356

CIRCRESAHA.113.300752

P1433

Circulation Research

P1476

Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond

@en

P2093

R. E. Kellems

http://www.w3.org/2001/XMLSchema#string

Y. Xia

http://www.w3.org/2001/XMLSchema#string

P2860

Soluble endoglin contributes to the pathogenesis of preeclampsia

Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression

Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension

Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia.

Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia

Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity.

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.

Agonist-like beta-adrenoceptor antibodies in heart failure.

P304

78-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

230468

http://www.w3.org/2001/XMLSchema#string

P356

10.1161/CIRCRESAHA.113.300752

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23788505

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

4131731

http://www.w3.org/2001/XMLSchema#string